Stefano Quintini

JPM is more than a snapshot of market sentiment; it’s where strategy starts to crystallize. In conversations with executives, investors, and operators across the week, the message was clear: 2026 feels more actionable than...more Artificial Intelligence is reshaping drug discovery. At SF @Tech Week by a16z, we co-hosted a fantastic session with @a16z on the rise of the AI-native scientist, where data-first labs, agentic systems, and copilots are...more The Fenwick life sciences team recently returned from the 2024 JP Morgan Healthcare conference. As we reflect back on the week, there were several key themes and trends that we expect will continue to resonate and evolve over...more The U.S. Department of Health and Human Services Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services (CMS), recently published rules implementing...more